LAUSR

et al. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania. BMC Med Genet. 2020;21:125. 12. Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu Y-J, et al. Corepressordependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci USA. 2013;110:6518–23. 13. Weber L, Frati G, Felix T, Hardouin G, Casini A, Wollenschlaeger C, et al. Editing a c-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Sci Adv. 2020;6:eaay9392. 14. Steinberg MH. Fetal hemoglobin in sickle cell anemia. Blood. 2020;118:19– 27. 15. Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342:253–7.